BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37690597)

  • 21. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
    Yadav SK; Nagori BP; Desai PK
    J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.
    Stepanović-Petrović R; Micov A; Tomić M; Pecikoza U
    Psychopharmacology (Berl); 2017 Jun; 234(11):1781-1794. PubMed ID: 28332005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated Dosing with NCX1404, a Nitric Oxide-Donating Pregabalin, Re-establishes Normal Nociceptive Responses in Mice with Streptozotocin-Induced Painful Diabetic Neuropathy.
    Varani K; Vincenzi F; Targa M; Ravani A; Bastia E; Storoni L; Brambilla S; Almirante N; Impagnatiello F
    J Pharmacol Exp Ther; 2016 May; 357(2):240-7. PubMed ID: 26907623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BTD: A TRPC5 activator ameliorates mechanical allodynia in diabetic peripheral neuropathic rats by modulating TRPC5-CAMKII-ERK pathway.
    Adhya P; Vaidya B; Sharma SS
    Neurochem Int; 2023 Nov; 170():105609. PubMed ID: 37673218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antinociceptive effects of a δ-opioid receptor agonist in mice with painful diabetic neuropathy: Involvement of heme oxygenase 1.
    Castany S; Carcolé M; Leánez S; Pol O
    Neurosci Lett; 2016 Feb; 614():49-54. PubMed ID: 26762785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Pregabalin and Duloxetine in Patients with Painful Diabetic Peripheral Neuropathy (PDPN): A Multi-Centre Phase IV Clinical Trial-BLOSSOM.
    Rakusa M; Marolt I; Stevic Z; Rebrina SV; Milenkovic T; Stepien A
    Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy.
    Kandhare AD; Raygude KS; Ghosh P; Ghule AE; Bodhankar SL
    Fitoterapia; 2012 Jun; 83(4):650-9. PubMed ID: 22343014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy-Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment.
    Matta C; Meyer L; Mensah-Nyagan AG; Taleb O
    Neurotox Res; 2020 Jun; 38(1):145-162. PubMed ID: 32108299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of Gelsemium-based treatment against paclitaxel-induced painful symptoms.
    Vitet L; Patte-Mensah C; Boujedaini N; Mensah-Nyagan AG; Meyer L
    Neurol Sci; 2018 Dec; 39(12):2183-2196. PubMed ID: 30251080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The selective TRPV4 channel antagonist HC-067047 attenuates mechanical allodynia in diabetic mice.
    Dias FC; Alves VS; Matias DO; Figueiredo CP; Miranda ALP; Passos GF; Costa R
    Eur J Pharmacol; 2019 Aug; 856():172408. PubMed ID: 31129158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photobiostimulation reverses allodynia and peripheral nerve damage in streptozotocin-induced type 1 diabetes.
    Rocha IRC; Ciena AP; Rosa AS; Martins DO; Chacur M
    Lasers Med Sci; 2017 Apr; 32(3):495-501. PubMed ID: 28138810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management.
    Jensen TS; Karlsson P; Gylfadottir SS; Andersen ST; Bennett DL; Tankisi H; Finnerup NB; Terkelsen AJ; Khan K; Themistocleous AC; Kristensen AG; Itani M; Sindrup SH; Andersen H; Charles M; Feldman EL; Callaghan BC
    Brain; 2021 Jul; 144(6):1632-1645. PubMed ID: 33711103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration.
    Hulse RP; Beazley-Long N; Ved N; Bestall SM; Riaz H; Singhal P; Ballmer Hofer K; Harper SJ; Bates DO; Donaldson LF
    Clin Sci (Lond); 2015 Oct; 129(8):741-56. PubMed ID: 26201024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective effects of ranolazine versus pioglitazone in experimental diabetic neuropathy: Targeting Nav1.7 channels and PPAR-γ.
    Elkholy SE; Elaidy SM; El-Sherbeeny NA; Toraih EA; El-Gawly HW
    Life Sci; 2020 Jun; 250():117557. PubMed ID: 32184124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diphenyleneiodonium Mitigates Bupivacaine-Induced Sciatic Nerve Damage in a Diabetic Neuropathy Rat Model by Attenuating Oxidative Stress.
    Ji ZH; Liu ZJ; Liu ZT; Zhao W; Williams BA; Zhang HF; Li L; Xu SY
    Anesth Analg; 2017 Aug; 125(2):653-661. PubMed ID: 28682956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug combinations in diabetic neuropathic pain: an experimental validation.
    Tripathi CD; Mehta AK; Yadav AM
    J Basic Clin Physiol Pharmacol; 2016 Nov; 27(6):617-624. PubMed ID: 27331307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of opioid receptor antagonists on electroacupuncture-produced anti-allodynia/hyperalgesia in rats with paclitaxel-evoked peripheral neuropathy.
    Meng X; Zhang Y; Li A; Xin J; Lao L; Ren K; Berman BM; Tan M; Zhang RX
    Brain Res; 2011 Sep; 1414():58-65. PubMed ID: 21872220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions.
    Visnagri A; Kandhare AD; Chakravarty S; Ghosh P; Bodhankar SL
    Pharm Biol; 2014 Jul; 52(7):814-28. PubMed ID: 24559476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of diabetic sensory polyneuropathy.
    Zilliox L; Russell JW
    Curr Treat Options Neurol; 2011 Apr; 13(2):143-59. PubMed ID: 21274758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
    Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R
    Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.